These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27942463)

  • 1. Multigene panel next generation sequencing in a patient with cherry red macular spot: Identification of two novel mutations in
    Mütze U; Bürger F; Hoffmann J; Tegetmeyer H; Heichel J; Nickel P; Lemke JR; Syrbe S; Beblo S
    Mol Genet Metab Rep; 2017 Mar; 10():1-4. PubMed ID: 27942463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and electrophysiological characteristics of a type 1 sialidosis patient with a novel deletion mutation in NEU1 gene.
    Fan SP; Lee NC; Lin CH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 3):406-412. PubMed ID: 31371146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 Sialidosis Patient With a Novel Deletion Mutation in the NEU1 Gene: Case Report and Literature Review.
    Ahn JH; Kim AR; Lee C; Kim NKD; Kim NS; Park WY; Kim M; Youn J; Cho JW; Kim JS
    Cerebellum; 2019 Jun; 18(3):659-664. PubMed ID: 30635863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Structural Characteristics of NEU1 Variants Causing Sialidosis Type 1.
    Li Y; Liu Y; Wang R; Ao R; Xiang F; Zhang X; Wang X; Yu S
    J Mov Disord; 2024 Jul; 17(3):282-293. PubMed ID: 38600684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 1 sialidosis presenting with ataxia, seizures and myoclonus with no visual involvement.
    Mohammad AN; Bruno KA; Hines S; Atwal PS
    Mol Genet Metab Rep; 2018 Jun; 15():11-14. PubMed ID: 30023283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I sialidosis, a normosomatic lysosomal disease, in the differential diagnosis of late-onset ataxia and myoclonus: An overview.
    Caciotti A; Melani F; Tonin R; Cellai L; Catarzi S; Procopio E; Chilleri C; Mavridou I; Michelakakis H; Fioravanti A; d'Azzo A; Guerrini R; Morrone A
    Mol Genet Metab; 2020 Feb; 129(2):47-58. PubMed ID: 31711734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathology of NEU1 gene in sialidosis.
    Seyrantepe V; Poupetova H; Froissart R; Zabot MT; Maire I; Pshezhetsky AV
    Hum Mutat; 2003 Nov; 22(5):343-52. PubMed ID: 14517945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal study of Taiwanese sialidosis type 1: an insight into the concept of cherry-red spot myoclonus syndrome.
    Lai SC; Chen RS; Wu Chou YH; Chang HC; Kao LY; Huang YZ; Weng YH; Chen JK; Hwu WL; Lu CS
    Eur J Neurol; 2009 Aug; 16(8):912-9. PubMed ID: 19473359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography features in a case of Type I sialidosis.
    Wang IH; Lin TY; Kao ST
    Taiwan J Ophthalmol; 2017; 7(2):108-111. PubMed ID: 29018767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialidosis type 1 without cherry-red spots: a case report and literature review.
    Zhang C; Liao Z; Zhou Y; Su X
    BMJ Neurol Open; 2024; 6(1):e000498. PubMed ID: 38361966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitfalls in Diagnosing Neuraminidase Deficiency: Psychosomatics and Normal Sialic Acid Excretion.
    Schene IF; Kalinina Ayuso V; de Sain-van der Velden M; van Gassen KL; Cuppen I; van Hasselt PM; Visser G
    JIMD Rep; 2016; 25():9-13. PubMed ID: 26141460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis.
    Bonten EJ; Yogalingam G; Hu H; Gomero E; van de Vlekkert D; d'Azzo A
    Biochim Biophys Acta; 2013 Oct; 1832(10):1784-92. PubMed ID: 23770387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygous mutations in the neuraminidase 1 gene in type 1 sialidosis: A case report and review of literature.
    Cao LX; Liu Y; Song ZJ; Zhang BR; Long WY; Zhao GH
    World J Clin Cases; 2021 Jan; 9(3):623-631. PubMed ID: 33553400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding sialidosis spectrum by genome-wide screening: NEU1 mutations in adult-onset myoclonus.
    Canafoglia L; Robbiano A; Pareyson D; Panzica F; Nanetti L; Giovagnoli AR; Venerando A; Gellera C; Franceschetti S; Zara F
    Neurology; 2014 Jun; 82(22):2003-6. PubMed ID: 24808020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and molecular characterization of novel mutations in GLB1 and NEU1 in patient cells with lysosomal storage disorders.
    Kwak JE; Son MY; Son YS; Son MJ; Cho YS
    Biochem Biophys Res Commun; 2015 Feb; 457(4):554-60. PubMed ID: 25600812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel spot mutation leading to sialidosis type 1-myoclonus syndrome and optical coherence tomography findings.
    Meşen S; Batur M; Ozer MD
    Arq Bras Oftalmol; 2023 Apr; ():. PubMed ID: 37018822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis.
    Pshezhetsky AV; Richard C; Michaud L; Igdoura S; Wang S; Elsliger MA; Qu J; Leclerc D; Gravel R; Dallaire L; Potier M
    Nat Genet; 1997 Mar; 15(3):316-20. PubMed ID: 9054950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialidosis Type I without a Cherry Red Spot- Is There a Genetic Basis?
    Neeraja K; Holla VV; Prasad S; Surisetti BK; Rakesh K; Kamble N; Yadav R; Pal PK
    J Mov Disord; 2021 Jan; 14(1):65-69. PubMed ID: 33121223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and Management of Type 1 Sialidosis: Clinical Insights from Long-Term Care of Four Unrelated Patients.
    Coppola A; Ianniciello M; Vanli-Yavuz EN; Rossi S; Simonelli F; Castellotti B; Esposito M; Tozza S; Troisi S; Bellofatto M; Ugga L; Striano S; D'Amico A; Baykan B; Striano P; Bilo L
    Brain Sci; 2020 Aug; 10(8):. PubMed ID: 32752208
    [No Abstract]   [Full Text] [Related]  

  • 20. Galactosialidosis Type IIb with Bilateral Macular Cherry-Red Spots but Mild Dysfunction.
    Fukuyo H; Inoue Y; Takahashi H; Hatano Y; Shibuya T; Sakai N; Kawashima H
    Case Rep Ophthalmol; 2020; 11(2):306-314. PubMed ID: 32774297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.